Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

France

 

French government puts on the squeeze

The French government has said it wants to limit rises in its €185bn healthcare budget to 1.75% a year, down from 2.5%. Meanwhile, all sectors are on tenterhooks ahead of the announcement of the new healthcare tariffs in early March 2014. None are so desperate as the private hospitals. Their trade association, FHP-MCO, claims the key MCO (Medicine, surgery and obstetrics) tariff has risen by a total of just 1.17% over the entire eight years to 2013. That is against general inflation for the period of 11.82%. We hear that the state now wants to CUT the tariff by 0.5-1%!

GHX sells to Thoma Bravo

GHX, the world's leading eCommerce and exchange platform for medtech products, has been bought from a consortium of 20 suppliers and providers by tech-focused US private equity house Thoma Bravo. What ramifications will this have for transparency in procurement? We talk to Bruce Johnson, GHX CEO, and look at the price of the deal.

Will supplementary insurance save French private providers?

Over the last three years, many people in the private sector have indicated that the real growth in France will come from the rise of supplementary insurance and the retreat of the state. “France will become a little more like America,” they tell us. The rise of supplementary insurance will give the private sector, from dentists to hospitals, the space they need to breathe. But is this really true?

Bribery in healthcare

The vast majority of bribes paid by citizens in Europe have to do with access to healthcare, according to an EU anti-corruption report. Healthcare and pharma businesses in Europe are also the most likely of any industry, with 77% agreeing, to think that corruption is widespread in their country. The report puts the total cost of corruption in the EU at €120bn - a little less than the annual EU budget. We look at the underlying numbers.

New record for bed prices in Paris

A new record for French nursing homes has been set in Paris, in a property deal that values each bed in a Parisian home at nearly €250,000.

Interview: Henk de Jong, CEO, Fa-Med

Will a pan-European market in medical factoring develop? Will we even see statutory pan-European healthcare insurers? We talk to Henk de Jong, CEO of Fa-Med, the largest medical factoring group in the Netherlands - and, probably, in Europe - which is looking at Germany, Poland and Switzerland. Fa-Med has been owned by Waterland private equity for over a decade. Henk is a delegate at the Healthcare Europa conference on March 13, 2014 in London.

Interview: Mark Hellowell, Lecturer, University of Edinburgh

Hellowell is a healthcare academic who specialises in PPPs, evaluating their performance around the world, consulting with development agencies and acting as a special adviser to the Health Select Committee in the British House of Commons. He also lectures on healthcare reform to a diverse group of postgraduate students, many of them from developing countries. We talk to him about the role private healthcare companies can, and are, playing in the developing and developed worlds, the future for PPPs, and whether they are “a good thing”.

Canada Pension Plan Investment Board backs Orpea’s international expansion

One of the world’s top 20 investors, with nearly C$200bn under management, has invested €321m for a 15% stake in French nursing home group Orpea, bought from company founder Jean-Claude Marian. The Canada Pension Plan Investment Board (CPPIB) says that it has bought into Orpea on the strength of its international expansion plans. The CPPIB also underwrote and bought 30% of a share issue to finance new growth. We look at CPPIB’s strategy, the state of play in the nursing home sector, and talk to Scott Lawrence, Vice President & Head of Relationship Investments at CPPIB.

Report: Healthcare procurement – low status, fragmented, impotent. So what is the solution?

We report from Healthcare Procurement Europe, the first pan-European forum to bring together procurement professionals, suppliers and policymakers to look at how procurement in Europe could be improved. This one-day event, held in November 2013 in London and sponsored by AT Kearney and Mesa Medical, consisted of a series of presentations followed by workshops.

Find Us